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Abstract
Background: Activation of naïve B lymphocytes by extracellular ligands, e.g. antigen, lipopolysaccharide (LPS) and CD40 ligand,
induces a combination of common and ligand-specific phenotypic changes through complex signal transduction pathways. For
example, although all three of these ligands induce proliferation, only stimulation through the B cell antigen receptor (BCR)
induces apoptosis in resting splenic B cells. In order to define the common and unique biological responses to ligand stimulation,
we compared the gene expression changes induced in normal primary B cells by a panel of ligands using cDNA microarrays and
a statistical approach, CLASSIFI (Cluster Assignment for Biological Inference), which identifies significant co-clustering of genes
with similar Gene Ontology™ annotation.
Results: CLASSIFI analysis revealed an overrepresentation of genes involved in ion and vesicle transport, including multiple
components of the proton pump, in the BCR-specific gene cluster, suggesting that activation of antigen processing and
presentation pathways is a major biological response to antigen receptor stimulation. Proton pump components that were not
included in the initial microarray data set were also upregulated in response to BCR stimulation in follow up experiments. MHC
Class II expression was found to be maintained specifically in response to BCR stimulation. Furthermore, ligand-specific
internalization of the BCR, a first step in B cell antigen processing and presentation, was demonstrated.
Conclusion: These observations provide experimental validation of the computational approach implemented in CLASSIFI,
demonstrating that CLASSIFI-based gene expression cluster analysis is an effective data mining tool to identify biological
processes that correlate with the experimental conditional variables. Furthermore, this analysis has identified at least thirty-eight
candidate components of the B cell antigen processing and presentation pathway and sets the stage for future studies focused
on a better understanding of the components involved in and unique to B cell antigen processing and presentation.
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Naïve mature B cells in peripheral lymphoid organs
respond to a variety of extracellular signals through the
activation of signal transduction pathways initiated by the
B cell antigen, pattern-recognition, cytokine and chemok-
ine receptors. B cell responses to signaling depend on the
combination of ligands present, and include activation,
proliferation, migration, differentiation, isotype class
switching, somatic hypermutation, anergy, and apoptosis
[1,2]. Once activated, B cells can also serve as antigen pre-
senting cells that preferentially present antigens recog-
nized by their specific BCR. In contrast, dendritic cells and
macrophages present varied antigens that are acquired less
specifically through phagocytosis, macropinocytosis and
receptor-mediated endocytosis via pattern-recognition
receptors such as the mannose receptor.
BCR-specific antigen processing and presentation is initi-
ated by BCR-mediated signal transduction triggered by
antigenic stimulation [3,4]. Antigen is then internalized
by receptor-mediated endocytosis and trafficked through
endosomes for acidification and fusion with lysosomes
containing pH-sensitive hydrolytic enzymes for antigen
processing. Endolysosomes containing processed anti-
genic peptides fuse with Golgi-derived vesicles containing
MHC class II molecules assembled with invariant chain
(Ii). The CLIP fragment of Ii bound in the cleft of the class
II aβ dimer is replaced by antigen-derived peptides and
the complex trafficked to the cell surface through vesicle
secretory pathways.
It is well known that B cell antigen processing and presen-
tation mediated through the BCR far exceeds the effi-
ciency of presentation of the same antigen by
macrophages or dendritic cells [5]. The mechanism giving
rise to this increased efficiency has not been fully deter-
mined but appears to be a unique aspect of BCR-mediated
antigen capture and processing as opposed to changes in
the basic antigen processing and presentation machinery
[6]. One mechanism that may contribute to efficiency is
accelerated trafficking of BCR/antigen complexes to Class
II containing vesicles inside the cell [7]. However, the
molecular mediators of this vesicle trafficking, especially
those components uniquely involved in the highly effi-
cient B cell antigen processing and presentation pathway,
have remained largely unknown.
We analyzed a B cell microarray dataset comparing the
responses of normal splenic B cells to 32 individual lig-
ands. This study was designed to determine functionally
important input signals to contribute to the understand-
ing of normal B cell biology and differs from existing B
cell microarray studies which largely compare normal B
cells to B cell lymphomas to identify tumor-specific gene
expression changes. By combining this gene expression
microarray analysis with bioinformatics analyses and
functional assays, we have identified a set of specific genes
that appear to be involved in BCR-mediated antigen cap-
ture, vesicle function and vesicle trafficking during B cell
antigen processing and presentation. These data provide a
foundation for the molecular characterization of this
important immunological process.
Results
Microarray analysis of ligand-treated B lymphocytes
Purified B lymphocytes were treated in culture with 32 dif-
ferent ligands over a timecourse of 30 min, 1 hr, 2 hr, and
4 hr. A detailed description of the data set has been pub-
lished [8]. Following filtering, normalization and SAM
analysis, genes that were differentially expressed by each
ligand in comparison with time-matched, untreated con-
trols were identified. Of the 32 ligands, CD40L, LPS, and
AIG caused the most gene expression changes, especially
at the 4 hr timepoint (Figure 1B). Further analysis focuses
on these three immunologically-important ligands. Cate-
gorical values of 1, -1, and 0 (representing significantly
upregulated, downregulated, or unchanged) were used to
group genes together based on their expression response
patterns (Table 1). Genes not differentially expressed
under at least one treatment condition were omitted from
further analysis. Based on 3 ligand combinations and a
possibility of 3 outcomes for each ligand (1, -1, 0), there
are a possible 33 or 27 gene clusters, with the (0, 0, 0) out-
come excluded since only genes that were differentially
expressed under at least one treatment condition were
selected (26 possible gene clusters). In our dataset, we
only observe 19 of these possible 26. A variety of different
expression patterns were observed. For example, Gene
Cluster #1 contains genes that are upregulated by all three
ligands, whereas Gene Cluster #14 contains genes that are
only upregulated in response to LPS.
CLASSIFI analysis links gene clusters to cellular physiology
Microarray expression data can be full of experimental
and biological noise, and many microarray probes are not
well characterized. We developed a gene cluster classifica-
tion method that circumvents these limitations and links
biological function with gene expression patterns derived
from microarray experiments. This method, termed CLAS-
SIFI, uses Gene Ontology™ annotation to identify signifi-
cant co-clustering of genes with similar biological
properties, based on the postulate that genes involved in
the same biological process would be coordinately
expressed.
CLASSIFI utilizes the gene description database developed
by the Gene Ontology™ (GO) Consortium [9] to reveal
co-clustering of genes with similar biological properties.
The GO annotates gene products with GO terms based
upon their molecular function, biological process, andPage 2 of 19
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Experimental methodology and analysis of microarray dataFigu e 1
Experimental methodology and analysis of microarray data. (A) Schematic of steps performed during microarray data 
processing. Gray boxes indicate steps performed as part of the CLASSIFI component of the analysis. See text for details. (B) 
The number of genes whose expression was significantly changed at the 4 hr timepoint as determined by SAM is shown for 
each of 32 ligands. Abbreviations and descriptions for each ligand can be found at [22]. 40L = CD40L (anti-CD40), LPS = 
Lipopolysaccharide, and AIG = anti-IgM.
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in a directed acyclic graph of parent-child relationships,
allowing a term to have multiple parents [10,11]. GO
gene annotation has also been used by other groups as a
tool for identifying biological processes relevant to gene
expression profiling experiments [11-13].
CLASSIFI measures the probability of co-clustering for
every gene ontology term designated to every gene in each
gene cluster. Gene expression data clustering and gene
cluster membership assignment generates the CLASSIFI
input file (See Additional file 1). CLASSIFI captures all of
the GO terms annotated to every probe and then calcu-
lates the probability of chance co-clustering of GO terms.
The final CLASSIFI output is a list of every GO term,
ranked within each gene cluster from lowest to highest
probability (See Additional file 2).
The filtered data set contained 2545 probes, which led to
the calculation of 5036 probabilities (See Additional file
3). The GO term with the lowest probability for each gene
cluster is shown in Table 1. A significance cutoff of 1 × 10-
5 was established using a Bonferroni correction with an
alpha of 0.05 and an n of 5036 (see [14] and references
therein). Six gene clusters give rise to GO terms with sig-
nificant probabilities: Gene Cluster #1, 6, 7, 8, 14, and 18.
Gene clusters identified by CLASSIFI to give significant
probabilities exhibit predictable expression patterns that
could be explained biologically, including gene clusters
characterized by ligand-specific expression induction.
Experimental noise may contribute to gene clusters with
insignificant probabilities that show unusual expression
patterns.
CLASSIFI results for some gene clusters are expected based
on our current understanding of B cell physiology. For
example, the GO term giving the lowest probability in
Gene Cluster #1 is "nucleus". This gene cluster represents
genes which are upregulated in response to all three lig-
ands: AIG, CD40L, and LPS, and includes genes involved
in transcription, replication and RNA processing. All three
of these ligands induce cellular activation [1,2,15] and
proliferation (data not shown), so we would expect these
kinds of nuclear genes to be highly expressed in B cells
stimulated with all three ligands. The GO term giving the
lowest probability in Gene Cluster #6 is "oxidoreductase
Table 1: Clustering and CLASSIFI results for data from 3 ligands
GO ID g f c n expt prob GO type GO term Cluster ID anti-CD40 LPS AIG
GO:0005634 2490 254 380 64 38.76 8.71E-06 CC Nucleus 1 1 1 1
GO:0009058 2490 141 180 25 10.19 1.36E-05 BP biosynthesis 2 1 1
GO:0008372 2490 1409 1 1 0.566 5.66E-01 CC CC unknown 3 1 -1 -1
GO:0046072 2490 2 160 2 0.129 4.10E-03 BP dTDP metabolism 4 1 1
GO:0009605 2490 30 3 2 0.036 4.18E-04 BP response to external stimulus 5 1 -1
GO:0016655 2490 14 331 11 1.861 4.94E-08 MF oxidoreductase activity, acting on 
NADH
6 1
GO:0005773 2490 12 11 4 0.053 1.00E-07 CC Vacuole 7 -1 -1 1
GO:0003779 2490 15 277 9 1.669 6.30E-06 MF actin binding 8 -1 -1 -1
GO:0016758 2490 6 245 4 0.59 1.17E-03 MF Transferase activity, transferring 
hexosyl groups
9 -1 -1
GO:0006417 2490 2 4 1 0.003 3.21E-03 BP regulation of protein biosynthesis 10 -1 1
GO:0008372 2490 1409 41 32 23.2 3.30E-03 CC CC unknown 11 -1 -1
GO:0008047 2490 10 160 3 0.643 2.23E-02 MF enzyme activator activity 12 -1
GO:0006397 2490 19 56 4 0.427 6.92E-04 BP mRNA processing 13 1 1
GO:0005576 2490 156 183 33 11.47 7.28E-09 CC extracellular 14 1
GO:0046916 2490 1 4 1 0.002 1.61E-03 BP transition metal ion homeostasis 15 -1 1
GO:0003931 2490 3 38 2 0.046 6.74E-04 MF Rho small monomeric GTPase 
activity
16 -1 -1
GO:0004032 2490 3 188 3 0.227 4.24E-04 MF aldehyde reductase activity 17 -1
GO:0015672 2490 10 191 7 0.767 1.38E-06 BP monovalent inorganic cation 
transport
18 1
GO:0016892 2490 3 50 2 0.06 1.17E-03 MF endoribonuclease activity, 
producing other than
19 -1
Gene clusters (Cluster ID 1–19) resulting from categorical clustering of processed data from B cells stimulated with anti-CD40, LPS, and AIG. "1" = 
upregulated, "-1" = downregulated, and blank = no significant change. Following CLASSIFI analysis, the GO term giving rise to the lowest probability 
in each gene cluster is indicated. GO ID = a unique Gene Ontology identifier assigned to a GO term that corresponds to a defined molecular 
function (MF), biological process (BP), or cellular component (CC). g = number of probes in the data set, f = number of probes with associated GO 
ID in the data set, c = number of probes in the gene cluster, n = number of probes with associated GO ID in the gene cluster. Expt = the expected 
number of occurrences of a given GO ID in a given cluster of size (n) based on a random distribution. Prob = the probability that the GO ID co-
cluster pattern has occurred by chance.Page 4 of 19
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shown that stimulation through CD40 and other TNF
family members results in the production of reactive oxy-
gen species through NADPH [16]. Importantly, many of
the GO terms giving the low probabilities in a given gene
cluster are functionally related, e.g. monovalent inorganic
ion transport, ion transport, transporter activity, and cat-
ion transport in Gene Cluster #18 (Table 2).
Experimental validation of CLASSIFI-derived biological 
predictions
CLASSIFI analysis should be viewed as a hypothesis-gen-
erating tool. While the statistical analysis is compelling,
predictions that derive from the hypotheses should be ver-
ified experimentally. We were particularly interested in
the AIG-specific Gene Cluster #18 because these genes
represent biological processes that are unique to antigenic
stimulation rather than the general activation responses
induced by all three ligands. The GO term giving the low-
est probability in Gene Cluster #18 is "monovalent inor-
ganic cation transport" (GO:0015672). An examination
of the genes annotated with this GO term revealed multi-
ple components of the vacuolar ATPase H+ pump (Table
3). Since stimulation through the BCR induces internali-
zation of the receptor-antigen complex and trafficking
through the endocytic system, "monovalent inorganic cat-
ion transport" could reflect the acidification of vesicles as
they progress from endosomes to lysosomes during endo-
cytosis. This AIG-specific cluster also contained an over-
representation of genes involved in general "transporter
activity" (GO:0005215), which includes genes like Rab9,
sorting nexin 5 (Snx5) and N-ethylmaleimide sensitive
fusion protein attachment protein alpha (Napa) that are
involved in endosome trafficking and vesicle fusion.
These observations led us to consider the hypothesis that
AIG might induce the expression of various components
of the endocytic and vesicle transport pathways in a man-
ner that is independent of its effects on the general meta-
bolic activation and proliferation of B cells, and that this
Table 2: Excerpt of CLASSIFI results for six gene clusters giving significant probabilities
GO ID f n prob GO type GO term Cluster ID
GO:0005634 254 64 8.71E-06 CC nucleus 1
GO:0005635 13 9 1.66E-05 CC nuclear membrane 1
GO:0006412 94 30 2.75E-05 BP protein biosynthesis 1
GO:0009059 94 30 2.75E-05 BP macromolecule biosynthesis 1
GO:0003743 20 10 2.68E-04 MF translation initiation factor activity 1
GO:0016655 14 11 4.94E-08 MF oxidoreductase activity, acting on NADH or NADPH, quinone or 
similar compound as acceptor
6
GO:0008137 14 11 4.94E-08 MF NADH dehydrogenase (ubiquinone) activity 6
GO:0015081 14 11 4.94E-08 MF sodium ion transporter activity 6
GO:0016651 16 11 4.61E-07 MF oxidoreductase activity, acting on NADH or NADPH 6
GO:0046873 16 11 4.61E-07 MF metal ion transporter activity 6
GO:0005773 12 4 1.00E-07 CC vacuole 7
GO:0016787 163 6 2.52E-05 MF hydrolase activity 7
GO:0005624 15 3 2.84E-05 CC membrane fraction 7
GO:0000267 18 3 5.05E-05 CC cell fraction 7
GO:0015991 3 2 5.31E-05 BP ATP hydrolysis coupled proton transport 7
GO:0003779 15 9 6.30E-06 MF actin binding 8
GO:0008092 22 9 3.08E-04 MF cytoskeletal protein binding 8
GO:0003785 6 4 1.88E-03 MF actin monomer binding 8
GO:0006357 10 5 2.58E-03 BP regulation of transcription from Pol II promoter 8
GO:0006355 79 17 4.85E-03 BP regulation of transcription, DNA-dependent 8
GO:0005576 156 33 7.28E-09 CC extracellular 14
GO:0005578 5 4 1.33E-04 CC extracellular matrix 14
GO:0004871 50 11 7.39E-04 MF signal transducer activity 14
GO:0004888 7 4 8.29E-04 MF transmembrane receptor activity 14
GO:0007166 25 7 1.59E-03 BP cell surface receptor linked signal transduction 14
GO:0015672 10 7 1.38E-06 BP monovalent inorganic cation transport 18
GO:0006811 23 10 2.65E-06 BP ion transport 18
GO:0005215 122 24 9.10E-06 MF transporter activity 18
GO:0006812 18 8 2.33E-05 BP cation transport 18
GO:0006754 4 4 3.36E-05 BP ATP biosynthesis 18
The five GO IDs giving the lowest probability are listed for each of six gene clusters giving significant probabilities in Table 1. GO ID = a unique 
Gene Ontology identifier that corresponds to a defined molecular function, biological process, or cellular component (GO name). f = number of 
probes with the associated GO ID in the data set, n = number of probes with the associated GO ID in the gene cluster. prob = the probability that 
the GO ID co-cluster pattern has occurred by chance.Page 5 of 19
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presentation function.
To ensure that the genes identified through the CLASSIFI
analysis were meaningful, we first sought to verify their
differential expression patterns. The microarray expres-
sion pattern of nine probes recognizing "transporter activ-
ity" genes in unstimulated and ligand-stimulated samples
were evaluated (Figure 2A). In every case, expression of
these genes was similar in all treatment conditions at 0.5
and 1 hr, but was higher in the AIG-treated samples at 2
hr and 4 hr. Examples in which the same gene is repre-
sented by two different probes show closely similar
expression patterns, indicating the high quality of this
microarray data set. To verify the ligand-specificity of
expression, RT-PCR was used to examine the expression of
a subset of these genes in independently-generated sam-
ples. Again, AIG induced enhanced expression of each of
these genes compared to LPS and anti-CD40 (Figure 2B).
RT-PCR results consistently confirm microarray expres-
sion data in this data set [8].
CLASSIFI analysis is based on the postulate that genes
involved in the same biological process are coordinately
expressed. Thus, one prediction of this analysis is that
other genes involved in the same biological process that
were not included in the microarray probe data set would
show the same expression pattern. We evaluated 4 such
genes that encode ATPase H+ pump complex subunits by
RT-PCR. All of these genes demonstrated a preferential
upregulation in response to AIG (Figure 2C). These data
not only provide experimental validation of the CLASSIFI
approach to microarray data analysis, but also further sup-
ports the hypothesis that AIG induces vesicle processing
and transport as a biological process.
In order to further test predictions that follow from the
CLASSIFI analysis we sought to determine if the process of
endocytosis is activated in a ligand/receptor-specific man-
ner. An internalization assay was performed in which the
BCR is fluorescently labeled with a non-stimulating anti-
IgM-FITC antibody prior to AIG treatment. After allowing
time for internalization, the cells are subjected to an acid
wash to remove surface-bound label. Label that has been
internalized is protected from the acid wash and can
therefore be detected using flow cytometry. Using this
method, we found that BCR internalization (arrow, Figure
3D) occurs with AIG stimulation, but not CD40L or LPS
stimulation in WEHI-231 cells (Figure 3A, G). Substantial
internalization was found as early as 15 minutes post-
stimulation and continued past 4 hours. Using fluores-
cence microscopy, internalized BCR can be seen in AIG-
treated cells by 10 minutes. No internalization of the BCR
is detected with anti-CD40 or LPS treatment (Figure 3J).
Ligand-specific internalization of the BCR was also
detected in primary B cells (data not shown).
To test whether receptor internalization following AIG
stimulation is specific to the BCR and not other cell sur-
face receptors, we performed internalization assays in
Table 3: Genes annotated with transport-related GO terms from Gene Cluster #18
GO ID Probe ID Gene Name
GO:0015672 C530010I21 ATPase, H+ transporting, V0 subunit B
GO:0015672 2310069H14 ATPase, H+ transporting, V1 subunit G isoform 1
GO:0015672 5730403E06 SIMILAR TO ATPASE, H+ TRANSPORTING, LYSOSOMAL
GO:0006811 2810002O05 sideroflexin 1
GO:0006811 1810048H22 arsA (bacterial) arsenite transporter, ATP-binding, homolog 1
GO:0006811 2310021D14 chloride channel 7
GO:0005215 1810011E08 MICROSOMAL SIGNAL PEPTIDASE 23 KDA SUBUNIT (EC 3.4.-.-)
GO:0005215 2810433C04 translocase of inner mitochondrial membrane 9 homolog (yeast)
GO:0005215 1500039N14 N-ethylmaleimide sensitive fusion protein attachment protein alpha
GO:0005215 2210039G11 fatty acid binding protein 5, epidermal
GO:0005215 5430437K12 zinc finger protein 295
GO:0005215 1810057M21 thioredoxin reductase 1
GO:0005215 2310004L13 translocase of inner mitochondrial membrane 9 homolog (yeast)
GO:0005215 2610025H03 fatty acid binding protein 5, epidermal
GO:0005215 5430413F24 RAB9, member RAS oncogene family
GO:0005215 5830417J06 24-dehydrocholesterol reductase
GO:0005215 0910001N05 sorting nexin 5
GO:0005215 2410046L22 FK506 binding protein 1a
GO:0005215 2010015D08 vacuolar protein sorting 29 (S. pombe)
GO:0005215 3010014K12 N-ethylmaleimide sensitive fusion protein attachment protein alpha
List of characterized genes detected using specific cDNA probes (Probe ID) found in Gene Cluster #18 that are associated with GO terms 
"monovalent inorganic ion transport" (GO:0015672), "ion transport" (GO:0006811), and "transporter activity" (GO:0005215). N.B. GO:0015672 is 
a child of GO:0006811, which is a child of GO:0005215 in the GO hierarchy.Page 6 of 19
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Expression data from select intracellular transport-related genesFigure 2
Expression data from select intracellular transport-related genes. (A) Microarray results for expression patterns of 
several genes over a timecourse of 0.5 to 4 hr. The log2(Cy5/Cy3) values were compared to 0 hr untreated samples (t = 0). 
Three examples of genes represented by two different probes (probe Ids in parentheses) are shown in the two right columns. 
(B) Real-time RT-PCR analysis of four intracellular transport-related genes at 4 hours of stimulation that were included in the 
microarray data set. Data were normalized to mouse 18S rRNA as a reference and compared to untreated samples. 
ATP6v0bc" and ATP6v1c1, n = 2. Sorting nexin V and Vacuolar protein 29S, n = 1. (C) Real-time RT-PCR analysis of 4 intracel-
lular transport-related genes at 4 hours of stimulation that were not included in the microarray data set.
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Internalization of cell surface receptors in WEHI-231Figure 3
Internalization of cell surface receptors in WEHI-231. (A-I) Assay for internalization of BCR, CD40, and TLR4 was per-
formed using WEHI-231 cells. Data from 1 hr stimulations are shown. Line thickness represents treatment of cells following 
labeling of receptor where thin = acid treated samples and thick = no acid treatment. Black = unstimulated, blue = LPS stimu-
lated, red = AIG stimulated, green = anti-CD40 stimulated. Arrow denotes histogram of acid-treated cells in which labeled 
BCR is protected from the effects of acid treatment with AIG stimulation. (J) Localization of the BCR by fluorescence micros-
copy. BCR are labeled with a non-stimulating FITC-conjugated monoclonal anti-IgM antibody (green) and treated for 10 min-
utes as indicated. DIC images are shown in bottom row.
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no internalization of the labeled receptor was detected
(Figure 3E, F), demonstrating that AIG induces specific
internalization of the BCR. (The slight shift in CD40 stain-
ing probably results from the upregulation of CD40 in
response to AIG treatment.) Finally, to test whether stim-
ulation of TLR4 with LPS or CD40 with anti-CD40
induces TLR4 or CD40 internalization, we fluorescently
labeled TLR4 or CD40, then treated cells with the corre-
sponding ligands. In the case of TLR4 stimulation with
LPS, no internalization is detected (Figure 3B). Anti-CD40
stimulation induces a rapid receptor shedding phenome-
non [17] and so it is difficult to directly compare the
results of these samples with the other treatment condi-
tions. However, no evidence for internalization was found
(Figure 3I). Thus, AIG induces a ligand-specific, receptor-
specific endocytic process that is likely designed to capture
specific antigen for processing and presentation.
Finally, MHC class II expression would be expected to be
high in B cells undergoing antigen processing and presen-
tation. We found that following overnight stimulation
with anti-IgM, CD40L, and LPS, Class II expression on
anti-IgM treated cells is sustained, while in CD40L and
LPS treated cells Class II expression is significantly down-
regulated (Figure 4). This ligand-specificity for mainte-
nance of Class II on the surface of anti-IgM-treated cells is
interesting because it suggests that B cells constitutively
express a high level of Class II on the cell surface in antic-
ipation of antigen presentation, which is then down-regu-
lated in stimulated cells unless they are stimulated
through the BCR. This idea that B cells are primed to
undergo antigen processing and presentation supports
observations in the literature that antigen processing and
presentation is accelerated with BCR stimulation. Further,
our preliminary data indicate that B cells show enhanced
stimulation of antigen-specific T cell clones in response to
BCR stimulation (data not shown).
Discussion
CLASSIFI analysis
In this paper we report the analysis of gene expression
responses of B lymphocytes to a panel of extracellular lig-
ands using CLASSIFI, a statistical approach that uses GO
annotation to identify significant co-clustering of related
genes, thus linking biological function with gene expres-
sion patterns derived from microarray experiments. CLAS-
SIFI circumvents two traditional limitations associated
with microarray expression analysis – the effects of exper-
imental and biological noise, and the variable depth of
knowledge of individual genes in the probe set. A well-
characterized gene has relatively precise annotations that
reach deep into the GO hierarchy, while a poorly-charac-
terized gene is only annotated with high level terms. By
capturing the entire ontology parentage of each gene,
CLASSIFI overcomes limitations associated with variable
depth-of-knowledge associated with most gene sets. In
addition, the probability calculation used in CLASSIFI is
relatively robust to the addition of experimental noise,
allowing the use of less stringent data filtering
approaches, which reduces the false negative discovery
rate without the usual associated increase in false posi-
tives. Indeed, increasing the SAM FDR followed by CLAS-
SIFI analysis increase the number of endocytosis-related
genes while maintaining similar gene cluster classifica-
tions (data not shown).
Our analysis focused on the AIG-specific Gene Cluster
#18, which was statistically classified as an intracellular
transport-related gene cluster. Inspection of the entire
gene list leads to the hypothesis that Gene Cluster #18
classification reflects the broader biological process of
BCR-mediated endocytosis, vesicle acidification and traf-
ficking, and antigen processing and presentation. CLAS-
SIFI should be considered a hypothesis-generating tool
that requires experimental validation. Several predictions
of our hypothesis were confirmed experimentally, includ-
ing ligand-specific endocytosis induction and MHC class
II expression.
It should be noted that although we have used gene ontol-
ogy annotation as a means of gene classification, any gene
description scheme of interest could be used with the
CLASSIFI approach to link experimental variables with
legacy knowledge through gene expression microarray
data.
Class II MHC expression in AIG, anti-CD40, and LPS stimu-lated WE I-231Figure 4
Class II MHC expression in AIG, anti-CD40, and LPS 
stimulated WEHI-231. Flow cytometric analysis of Class II 
I-Ad expression in WEHI-231 in response to overnight stimu-
lation with AIG (red), anti-CD40 (green), and LPS (blue) or 
media alone (thick black line). Thin black line represents the 
unstained control.
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untreated
unstainedPage 9 of 19
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Table 4: Manual curation of Gene Cluster #18 genes
Protein description Gene Sym Symbol LocusLink ID Function Reference
A CD72 Cd72 12517 BCR coreceptor 32–34 35
dual specificity phosphatase 14 Dusp14 56405 lymphocyte signaling 36
mitogen activated protein kinase kinase kinase kinase 1 Map4k1 26411 lymphocyte signaling 37–39
mitogen activated protein kinase kinase 3 Map2k3 26397 lymphocyte signaling 40, 41
serine/threonine kinase receptor associated protein Strap 20901 TGFbeta signaling 42
dishevelled associated activator of morphogenesis 1 Daam1 208846 Wnt signaling 43
FK506 binding protein 1a Fkbp1a 14225 BCR signaling/apoptosis 44–46
nuclear factor of activated T-cells, cytoplasmic 2 interacting 
protein
Nfatc2ip 18020 BCR signaling/apoptosis 44–46
sorting nexin 5 Snx5 69178 endocytosis 47, 48
IQ motif containing GTPase activating protein 1 Iqgap1 29875 vesicle formation 49, 50
amyotrophic lateral sclerosis 2 (juvenile) homolog (human) Als2 74018 endosome fusion/Rab GEF 51, 52
RAB18, RAS family Rab18 19330 endocytosis/vesicle recycling 53–56 56
RAB22, RAS family Rab22a 19334 early endosome trafficking 56, 57
Proton pump, subunit V0B (21 kDa) Atp6v0b 114143 vesicle acidification 58–60
Proton pump, subunit V1G1 (13 kDa) Atp6v1g1 66290 vesicle acidification 58–60
Proton pump, subunit V1C1 (42 kDa) Atp6v1c1 66335 vesicle acidification 58–60
similar to Proton pump, subunit V1F 76610 vesicle acidification 58–60
Proton pump accessory protein 2 Atp6ap2 70495 vesicle acidification 61, 62
Chloride channel 7 Clcn7 26373 vesicle pH regulation 63, 64
dystrobrevin binding protein 1 (dysbindin) Dtnbp1 94245 lysosome formation 65
cystatin B Cstb 13014 cathepsin protease inhibitor 66–68
hexosaminidase A Hexa 15211 hydrolase 69–71
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-
Vogt disease)
Cln3 12752 lysosome function 72
HSP70 binding protein Hspbp1 66245 Ag processing/loading 73
similar to HSPC135 66067 chaperone (?), GTPase (?)
HSPC245 homolog chaperone (?)
N-ethylmaleimide sensitive fusion protein attachment protein 
alpha
Napa 108124 vesicle fusion 74, 75
RAB9, RAS family Rab9 56382 vesicle tethering 76, 77
activating transcription factor 1 Atf1 11908 MHC expression 78
Sec61 alpha Sec61a1 53421 ER translocation 79
signal sequence receptor, alpha Ssr1 107513 MHCII chaperone 80
calmegin Clgn 12745 MHC chaperone 81, 82
similar to signal peptidase SPC22/23 76687 secretory protein processing 83
vacuolar protein sorting 29 Vps29 56433 retrograde vesicle transport 84, 85
reticulon 3 Rtn3 20168 exocytosis 86, 87
tubulin, alpha 6 Tuba6 22146 cytoskeletal trafficking 88, 89
CD63 Cd63 12512 MHCII coreceptor 90–92
source of immunodominant MHC-associated peptides Simp 68292 MHC peptide 93
B 24-dehydrocholesterol reductase Dhcr24 74754 Cholesterol biosynthesis 94
fatty acid binding protein 5, epidermal Fabp5 16592 Fatty acid intracellular 
transport
95
phosphatidylethanolamine binding protein Pbp 23980 Membrane lipid transport 96
prostaglandin D2 synthase 2, hematopoietic Ptgds2 54486
peroxisome biogenesis factor 1 Pex1 71382 Peroxisomal protein tranport 97
C beclin 1 (coiled-coil, myosin-like BCL2-interacting protein) Becn1 56208 Tumor suppression 98, 99
caspase 4, apoptosis-related cysteine protease Casp4 12363 Apoptosis 100–102
Cd27 binding protein (Hindu God of destruction) Siva 30954 Apoptosis 103, 104
D polymyositis/scleroderma autoantigen 2 Pmscl2 50912 RNA processing autoantigen 105
Sjogren's syndrome/scleroderma autoantigen 1 homolog (human) Sssca1 56390 centromeric autoantigen 106
amyotrophic lateral sclerosis 2 (juvenile) homolog (human) Als2 74018 endosome fusion/Rab GEF 51, 52
Genes found in Gene Cluster #18 with functions related to (A) intracellular trafficking, BCR signaling, vesicle processing and function, and antigen 
processing and presentation, (C) apoptosis, and (D) B cell-related autoimmune disease. (B) Genes annotated with "transporter" activity whose roles 
are not yet known to be associated with intracellular trafficking.
BMC Bioinformatics 2006, 7:237 http://www.biomedcentral.com/1471-2105/7/237Identification of putative components of BCR-mediated 
antigen capture, processing, and presentation (see Table 4 
for reference to this section)
Based on the genes responsible for Gene Cluster #18 clas-
sification (Table 3), we hypothesized that BCR engage-
ment activates receptor-mediated endocytosis, vesicle
acidification, vesicle trafficking, and antigen processing
and presentation. We manually curated the AIG-specific
cluster gene list and found a total of 38 genes, including
those identified using CLASSIFI, that might be involved
based on the molecular functions defined in other cell sys-
tems and biological processes from the literature (Table
4A). Figure 5 shows a schematic representation of the B
cell antigen processing and presentation pathway indicat-
ing the putative roles played by these genes.
Several genes known to be involved in signal transduction
were found in Gene Cluster #18; some have been demon-
strated to play a role in BCR signaling while others are
involved in signaling pathways in other cell types and are
candidates for new BCR signaling components that stim-
ulate the endocytic process (Table 4A). Activation of pro-
tein kinases, including members of the MAP kinase
family, in response to BCR engagement is well docu-
mented; thus Strap, Map4k1 (Hpk1) and Map2k3 may
also play a role in BCR signaling. Indeed, Map4k1 is
expressed in hematopoietic cells and is required for acti-
vation-induced T cell death following TCR stimulation,
and Map2k3 is required for IL-12 production by macro-
phages and dendritic cells, and antigen-mediated activa-
tion of T cells. CD72 has been found to regulate the
Gene Cluster #18 contains genes involved in several aspects of vesicle processing, intracellular trafficking, and antigen process-ing and presentationFi ure 5
Gene Cluster #18 contains genes involved in several aspects of vesicle processing, intracellular trafficking, and 
antigen processing and presentation. A manual curation of the gene list comprising Gene Cluster #18 resulted in this 
detailed model of intracellular transport processes in B cells (refer to text for details). EE = early endosome, LE = late endo-
some, RE = recycling endosome, ELYS = endolysosome, LYS = lysosome, RER = endoplasmic reticulum, TGN = trans-Golgi 
network, NUCL = nucleus.Page 11 of 19
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recruitment of the SHP-1 phosphatase thereby dampen-
ing BCR signaling, or by cooperating with BCR signaling
to prevent apoptosis in immature B cells. The Dusp14
dual specificity phosphatase has been found to associate
with the CD28 co-receptor and dampen TCR-mediated
signaling in T cells by inactivation of MAP kinases, sug-
gesting that it may regulate BCR signaling in a similar
fashion. Daam1 is involved in Wnt signaling in Xenopus
embryogenesis. Strap binds to the TGF beta type I receptor
and inhibits downstream signaling. Whether these pro-
teins might play a role in regulating BCR signaling
remains to be determined. The NF-ATc2 isoform has been
found to participate in the BCR-induced apoptosis in B-
cell-derived Burkitt's lymphoma cell lines, thus the pres-
ence of Nfatc2ip and Fkbp1 suggests that these interacting
proteins may also be important in regulating Ca++/cal-
modulin/calcineurin/NFAT signaling in B cells.
A large proportion of genes in Gene Cluster #18 encode
proteins with roles in endocytosis, vesicle trafficking, ves-
icle acidification, molecular processing and protein secre-
tion. In most cases these roles have been defined in other
cell systems. Since little is known about the molecular
details of these processes in receptor-mediated antigen
capture and MHC class II-dependent antigen processing
and presentation in B cells, the possibility that Gene Clus-
ter #18 has produced a putative list of proteins that coor-
dinate these activities is intriguing.
Snx5, a member of the sorting nexin family, has been
found to interact with clathrin in skeletal muscle. Clathrin
has been implicated in facilitating membrane invagina-
tion during receptor-mediated endocytosis in B cells. The
presence of Snx5 in this cluster suggests that it may help
mediate this process. The Als2 protein acts as a guanine
nucleotide exchange factor for Rab5 and Rac1, and stimu-
lates early endosome fusion. Rab proteins are small
GTPases with homology to Ras that play key roles in vesi-
cle transport: Rab18 has been found to localize near the
apical and basolateral plasma membrane in epithelial
cells of the kidney and intestine and Rab22a has been
found to localize to the plasma membrane and early
endosomes. Iqgap1 is a scaffolding protein with multiple
protein-protein interaction domains and a GTPase activa-
tion protein (Gap) domain that stimulates the hydrolytic
activity of Ras family members. Iqgap1 has also been
found to localize to areas of membrane ruffling and newly
formed vesicles in astrocytoma cells.
Genes encoding homologs to several components of the
vesicle-type proton pump were found in Gene Cluster
#18, including Atp6v0b, Atp6v1g1, Atp6v1c1, and
Atp6v1f and the proton pump accessory protein Atp6ap2.
Additional proton pump components were also found to
be induced in an AIG-specific manner by RT-PCR
(Atp6v0c, Atp6va1, Atp6v1h and Atp6v1a1). Together
with the vesicle-specific chloride channel Clcn7, these
proteins are likely to play a role in the acidification of the
endocytic vesicles in preparation for their fusion with lys-
osomes to facilitate antigen hydrolysis. Proton pump
components can serve as a membrane anchor point for
SNARE proteins. Napa appears to mediate the tethering of
these vesicles in preparation for fusion. Rab9 also appears
to play a role in vesicle fusion since mutations in Rab9
lead to the accumulation of lipid-rich vesicles.
Several proteins involved in lysosome formation and anti-
gen processing were found in Gene Cluster #18. Dysbin-
din binds to dystobrevins and is a component of the
biogenesis of lysosome-related organelles complex 1 in
mouse liver, which regulates trafficking to lysosomal
organelles. Mutations in the Cln3 gene leads to a lyso-
somal storage disorder associated with the accumulation
of lipopigment-laden vesicles. Hexosaminidase A is a pH-
sensitive hydrolase. A variety of cathepsins are involved in
MHC Class II antigen processing and presentation. None
of the probes for these genes passed our data filtering
process, however the cathepsin inhibitor Cystatin B was
found in Gene Cluster #18, suggesting that it might play a
role in regulating cleavage site selection by modifying the
relative activities of proteases involved in antigen process-
ing and peptide loading. Hspbp1 may facilitate antigen
processing by regulating the chaperone function of
Hsp70, which has been associated with the presentation
of myelin basic protein though MHC class II in multiple
sclerosis.
Several genes involved in MHC class II expression were
found in the AIG-specific gene cluster. Atf1 is a transcrip-
tion factor that activates the promoter of the class II trans-
activator (CIITA). Translocation of nascent MHC class II
peptide chains into the lumen of the endoplasmic reticu-
lum involves the function of the Sec61 translocation com-
plex, the signal sequence receptor Ssr1 (a.k.a. TRAP alpha)
and the signal peptidase SPC22. Calmegin (Clgn) is a Ca++
binding chaperone protein with significant homology to
calreticulin and calnexin, an ER chaperone protein that
regulates the assembly of MHC class II with the Ii invari-
ant chain.
Vesicles containing peptide-loaded MHC class II are trans-
ported to the plasma membrane for fusion and exposure
on the cell surface, perhaps by traveling back through the
TGN into the secretory pathway. The Vsp29 protein has
been found to facilitate this kind of retrograde TGN trans-
port in yeast. In neurons, reticulon 3 is associated with
synaptophysin in tubulovesicular structures and may play
a role in the process of vesicle secretion. CD63, an MHCPage 12 of 19
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receptor compartmentalization.
38 genes found in Gene Cluster #18 encode proteins that
have some connection with signaling, antigen capture,
vesicle transport, vesicle acidification or MHC class II
expression, suggesting that activation of B cells through
the BCR is inducing the expression of genes involved in
MHC class II antigen processing and presentation. The
activation of class II presentation by antigen receptor
engagement in B cells has been described extensively. The
findings reported here are novel in that microarray results
combined with CLASSIFI analysis have provided a list of
genes that may be involved in this important immunolog-
ical process.
Finally, it is intriguing to note the presence of genes
involved in the regulation of apoptosis and autoimmu-
nity (Table 4C and 4D) in Gene Cluster #18, given the
known function of the BCR in negative selection and the
induction of autoimmunity.
Transcriptional positive feedback
The changes in mRNA levels for these genes involved in
vesicle trafficking might be necessary to stimulate this bio-
logical process in AIG-stimulated B cells. However, the
kinetics of the mRNA changes compared with the rapid
induction of endocytosis suggests that this may not be the
case. Elevated mRNA levels for these genes was found at 2
and 4 hr, but not at 0.5 or 1 hr post-stimulation. However,
BCR endocytosis was maximally stimulated by 15 min-
utes. The rapid induction of endocytosis suggests that at
least the initiation of this process is activated through
post-transcriptional mechanisms. This finding suggests
that the AIG-specific transcriptional reprogramming
observed in response to BCR stimulation may reflect pos-
itive feedback regulation in which expression of proteins
that have already been activated is increased either as a
means to amplify or sustain the process. Perhaps compo-
nents of this important biological process are present at
low levels in resting cells, and levels increase in response
to appropriate environmental cues. This kind of regula-
tory process might allow cells to respond rapidly to a
broad set of variables in their changing environment
while conserving energy and materials while in a resting
state.
Conclusion
In this paper, we describe a bioinformatics analysis of a B
cell microarray dataset using CLASSIFI to determine the
biological significance of microarray gene clusters defined
by ligand-specific B cell responses. Importantly, results
from laboratory experimentation support the hypotheses
derived from this microarray data mining exercise. This
work is a model for immunologists and other biologists
for utilizing the growing field of bioinformatics for micro-
array data mining, hypothesis generation and hypothesis
testing. Furthermore, the results from this analysis provide
a foundation for a more detailed understanding of the B
cell antigen processing and presentation pathway.
Methods
Primary B cell isolation and culture
Isolation of primary splenic murine B cells was performed
as described in the Alliance for Cellular Signaling (AfCS)/
Nature Signaling Gateway website [18]. Briefly, spleno-
cytes from 6–10 week old C57BL/6 mice were subjected to
a magnetic bead negative selection procedure (Miltenyi
Biotech, Auburn, CA) to remove CD43+ and Mac-1+ cells,
resulting in an enriched population of resting B cells that
was an average of 96% B220+, as determined by flow
cytometry [19]. Purified B cells were cultured in supple-
mented Iscove's Modified Dulbecco's Medium [20] with
100 U/ml penicillin and 100 µg/ml streptomycin (Invitro-
gen, Carlsbad, CA) at 37°C under 5% CO2. For microar-
ray and internalization experiments, cells were treated for
0.5 hr, 1 hr, 2 hr, and 4 hr with media alone, or with mu
chain specific Goat anti-mouse immunoglobulin, (AIG)
(Jackson Immunoresearch) at 45 µg/ml, hamster anti-
mouse CD40 monoclonal antibody, clone HM40-3 (BD
Pharmingen) at 9.73 µg/ml, or lipopolysaccharide (LPS)
(Sigma-Aldrich) at 40 µg/ml. For real-time PCR experi-
ments, cells were treated with anti-IgM at 20 µg/ml or
anti-CD40 at 625 ng/ml.
Microarray analysis and clustering
Microarray-related experimental protocols can be found
at the AfCS/Nature website at [21]; protocol IDs are:
PP00000009-RNA extraction, PP00000019-sample prep-
aration and hybridization. Briefly, RNA samples isolated
from B cells treated with a panel of 32 ligands were com-
pared with untreated samples using a microarray chip
containing 15,494 cDNA probes printed on 15,832 spots
representing 10,615 unique MGI gene matches (as of 12/
31/03). 38% of the probes have not been assigned a gene
name, 96% come from the RIKEN FANTOM collection,
3% from the Minoro Ko National Institute of Aging collec-
tion, and the rest from the Research Genetics and Genome
Systems collections. RNA samples were used to generate
Cy5- and Cy3-labeled cDNA targets (from sample RNAs
and RBC-depleted total splenocyte RNA, respectively) and
were hybridized together. All samples were run in tripli-
cate except for 1 hr and 4 hr untreated controls, which
were run in quadruplicate. Arrays were scanned using the
Agilent Scanner G2505A (Agilent Technologies, Palo Alto,
CA). Image files were analyzed using the Agilent
G2566AA Feature Extraction software version A.6.1.1. The
raw data from these experiments is available at [22]. Spot
features on each array were filtered to remove those values
that were saturated, non-uniform, or below background.Page 13 of 19
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Analysis of Microarrays (SAM) [23]. Features found by
SAM to be differentially expressed between samples and
time-matched untreated controls at a false discovery rate
(FDR) of 1% were included for further analysis. Input for
SAM were background-subtracted, dye bias- and interar-
ray variance-normalized Cy5 fluorescence intensity val-
ues, which represent expression level of array features.
Only features with more than two replicates were used in
the SAM analysis. 100 random permutations were done
for each comparison of treated to time-matched control
samples. Values of +1, -1, or 0 were given to genes that
were found by SAM to be significantly upregulated, down-
regulated, or unchanged (respectively) compared to time-
matched untreated controls. These values were used to
categorically group genes together based on their expres-
sion response patterns.
CLASSIFI analysis
Cluster Assignment for Biological Inference (CLASSIFI)
was developed as a method for statistical evaluation of
Gene Ontology™ (GO) term co-clustering (Figure 1A).
CLASSIFI is predicated on the postulate that genes
involved in the same biological process are coordinately
expressed; examples of coordinate expression of interact-
ing proteins in eukaryotes has been described [24-27].
Following data transformation, filtering, normalization,
standard expression clustering approaches and gene clus-
ter membership assignment, the following steps are per-
formed in the CLASSIFI analysis: 1) remove duplicate
probe IDs, 2) extract the primary GO annotations for each
gene from a probe database, 3) capture the full GO ances-
try for each primary GO annotation from the Gene Ontol-
ogy™ database, and 4) calculate the solution for the
cumulative hypergeometric distribution equation for
every GO term in every gene cluster:
where g = number of probes in the data set, c = number of
probes in the gene cluster, f = number of probes with a
given ontology in the data set, n = number of probes with
a given ontology in the gene cluster. The hypergeometric
distribution calculates the probability (P) that genes with
a particular GO term would co-cluster by chance given the
proportion of genes annotated with this GO term in the
entire data set. A web interface for use of the CLASSIFI
method with data derived from cDNA, oligonucleotide
and Affymetrix microarrays, along with detailed informa-
tion about CLASSIFI input and output files can be found
at the CLASSIFI website [28].
Quantitative real-time reverse-transcription-polymerase 
chain reaction
Total RNA was extracted as for the microarray experi-
ments. 1 µg of total RNA was treated with DNaseI (Invit-
rogen), then reverse transcribed at 42°C for one hour in a
20 µl volume containing 1 µl MMLV reverse transcriptase
(Invitrogen), 4 µl 5X buffer (Invitrogen), 0.5 mM dNTPs
(Invitrogen), and 5 ng/µl pd(N)6 (Amersham). Following
inactivation at 70°C for 20 min, PCR reactions were set up
in a 20 µl volume using Sybr Green Master Maker
(Applied Biosystems). Thermal cycling began with a dena-
turation step of 10 minutes at 95°C, followed by 40 cycles
of 95°C for 15 seconds (denaturation) and 60°C for 1
minute (annealing and extension). PCR reactions were
performed in the ABI Prism 7700 Sequence Detector (PE
Biosystems, Foster City, CA), and data collected and ana-
lyzed with the Sequence Detector software (PE Biosys-
tems). Standard curves were generated using RNA isolated
from RBC-depleted mouse splenocytes. RT-PCR of mouse
18S rRNA levels was used for normalization. Data from
treated samples were compared to untreated samples, giv-
ing values representing the fold change in gene expression
relative to untreated samples. PCR primers were designed
using Primer3 software [29]: ATP6v0Bc" forward (f)
5'gaaccccagcctctttgtaa3', reverse (r)
5'cccatcttcactctggaggt3'; ATP6v1c1 (f)
5'tgcttgccaaagaggtaaca3', (r) 5'tcgctgcatgtagtttctcc3'; sort-
ing nexin V (f) 5'gggagaaggggaaggatcta3', (r)
5'catgggtggacacagtcttc3'; vacuolar protein 29S (f)
5'ctgcagaggcagtttgatgt3', (r) 5'ggcagaacctgggttaatgt3';
ATP6v0c (f) 5'atgtcagtcatgaggccaga3', (r)
5'agcgataagtactgccacca3'; ATP6v0a1 (f)
5'tccacccagtctgtaggtga3'. (r) 5'atcatgatcagggtgcagaa3';
ATP6v1h (f) 5'gatgctgctgtcccaactaa3', (r)
5'agaaatcatctgcccctgaa3'; ATP6v1a1 (f)
5'gaattatgatgcgtccgatg3', (r) 5'cgcctgggatagcagtagtt3'.
Mouse 18S PCR primers sequences are from [30]: (f)
5'gtaacccgttgaaccccatt3', (r) 5'ccatccaatcggtagtagcg3'.
Internalization assays and flow cytometry
1 × 106 WEHI-231 cells (a mouse B cell lymphoma line)
were pre-stained for 10 min at 4°C with monoclonal anti-
bodies to cell surface receptors: Rat anti-IgM-FITC clone
R6-60.2 or clone II/40 (BD Pharmingen), Rat anti-CD40-
FITC clone 3/23 (BD Pharmingen), or Rat anti-TLR4/
MD2-PE clone MTS510 (eBiosciences). Following 2
washes in PBS/2% FBS/2 mM EDTA, cells were cultured
and stimulated using the aforementioned ligand concen-
trations in RPMI supplemented with 10% FBS (Hyclone),
100 U/ml penicillin, 100 µg/ml streptomycin (Invitrogen,
Carlsbad, CA), sodium pyruvate, HEPES, and 2-ME (Inv-
itrogen). Following incubation at 37°C with 5% CO2 for
various time periods, cells were harvested and incubated
at 4°C for 5 minutes in 0.2 M Acetic acid/0.5 M NaCl to
strip off staining antibodies [31], or in PBS/2% FBS/2 mM
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0.5 M NaCl or PBS/2% FBS/2 mM EDTA, respectively,
samples were fixed in 1% paraformaldehyde. Data were
acquired using a FACSCalibur™ flow cytometer and ana-
lyzed using CellQuest™ software (Becton Dickinson
Immunocytometry Systems).
MHC class II expression was measured by flow cytometric
analysis using FITC-conjugated antibody against I-Ad
clone 39-10-8 (BD Pharmingen).
BCR localization by immunofluorescence microscopy
1 × 106 WEHI-231 cells were harvested and resuspended
in 100 µl PBS containing 2% FBS. 2 µl of rat anti-IgM-FITC
clone R6-60.2 antibody was added, and cells incubated on
ice for 10 minutes to allow BCR staining. R6-60.2 was
determined to be non-stimulating because it did not flux
calcium or induce detectable tyrosine phosphorylation in
these cells (data not shown). Following one wash in PBS/
2%FBS, cells were resuspended in 100 ul phenol-red free
growth medium (Invitrogen) and kept on ice prior to
stimulation. Cells were stimulated by addition of ligands
at the following concentrations: AIG, 20 µg/ml; HM40-3,
9.73 µg/ml; or LPS, 40 µg/ml. Images were captured at
room temperature immediately following ligand stimula-
tion for up to 10 min. Using the Zeiss Axioplan 2 upright
fluorescence microscope (Carl Zeiss, Inc, Thornwood,
NY), images were captured with the 60X objective under
oil immersion using the OpenLab™ software, version
4.0.1 (Improvision, Boston, MA). 2 images were captured
for each field of view: one for detection of FITC fluores-
cence, and one for differential interference contrast (DIC)
imaging of cells. Images were processed using OpenLab™.
Abbreviations
Ligand abbreviations:
2MA - 2-Methyl-thio-ATP
AIG - Antigen (Anti-Ig)
BAF - BAFF (B-cell activating factor)
BLC - BLC (B-lymphocyte chemoattractant)
BOM - Bombesin
40L - CD40 ligand
CGS - CGS-21680 hydrochloride (2-p-[2-Carboxye-
thyl]phenethylamino-5'-N-ethylcarboxamidoadenosine)
CPG - CpG-Containing Oligonucleotide
DIM - Dimaprit
ELC - ELC (Epstein Barr Virus-induced molecule-1 Ligand
Chemokine)
FML - fMLP (formyl-Met-Leu-Phe)
GRH - Growth hormone-releasing hormone
IGF - Insulin-like growth factor 1
IFB - Interferon-beta
IFG - Interferon-gamma
I10 - Interleukin 10
I04 - Interleukin 4
LPS - Lipopolysaccharide
LB4 - Leukotriene B4 (LTB4)
LPA - Lysophosphatidic acid
M3A - MIP3-alpha (Macrophage inflammatory protein-3)
NEB - Neurokinin B
NPY - Neuropeptide Y
NGF - NGF (Nerve Growth Factor)
PAF - Platelet activating factor
PGE - Prostaglandin E2
SDF - SDF1 alpha (Stromal cell derived factor-1)
SLC - SLC (Secondary lymphoid-organ chemokine)
S1P - Sphingosine-1-phosphate
TER - Terbutaline
TNF - Tumor necrosis factor-alpha
TGF - Transforming growth factor-beta 1
Other Abbreviations:
BCR - B cell receptor
CLASSIFI - Cluster Assignment for Biological Inference
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